FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39925511000001107: Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Aug 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1980171000001116 Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1980181000001119 Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Is a Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Has specific active ingredient Valsartan true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) 28 tablet Has AMP True Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start